Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Viemed Healthcare (VMD) Revenue (2018 - 2026)

Viemed Healthcare filings provide 8 years of Revenue readings, the most recent being $76.2 million for Q4 2025.

  • On a quarterly basis, Revenue rose 25.51% to $76.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $270.3 million, a 20.52% increase, with the full-year FY2025 number at $270.3 million, up 20.52% from a year prior.
  • Revenue hit $76.2 million in Q4 2025 for Viemed Healthcare, up from $71.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $76.2 million in Q4 2025 to a low of $27.4 million in Q2 2021.
  • Median Revenue over the past 5 years was $46.4 million (2023), compared with a mean of $46.7 million.
  • Biggest five-year swings in Revenue: tumbled 36.06% in 2021 and later skyrocketed 38.15% in 2023.
  • Viemed Healthcare's Revenue stood at $32.0 million in 2021, then grew by 17.35% to $37.5 million in 2022, then surged by 35.28% to $50.7 million in 2023, then increased by 19.62% to $60.7 million in 2024, then rose by 25.51% to $76.2 million in 2025.
  • The last three reported values for Revenue were $76.2 million (Q4 2025), $71.9 million (Q3 2025), and $63.1 million (Q2 2025) per Business Quant data.